An obscure FDA rule aiding blockbuster drug profits By: CNBC.com News December 02, 2015 at 07:00 AM EST An FDA rule created to spur drug companies to develop treatments for rare diseases is being used far beyond its original scope, critics say. Read More >> Related Stocks: Rogers Corp